DxTerity Earns SOC 2 Type 2 Compliance, Reinforcing Commitment to Secure Healthcare Data. Read more
 
DxTerity Logo

Whitepaper

img white paper 1 thumbnail

New lupus therapies target the IFN-1 pathway

New data shows IFN-1 high patients have a better response to certain therapies

 

Better health management begins
at home

Subscribe to receive the latest information on new developments and products at DxTerity.